• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Using graphene and tiny droplets to detect stomach-cancer causing bacteria

Bioengineer by Bioengineer
June 20, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Osaka University-led researchers create a graphene-based biosensor to detect stomach-cancer causing bacteria by using microfluidics to keep the reaction products from the bacteria close to the graphene sensing element

IMAGE

Credit: Osaka University

Osaka, Japan – Biosensors are currently used in healthcare to monitor blood glucose; however, they also have the potential to detect bacteria. Researchers at Osaka University have invented a new biosensor using graphene–a material consisting of a one-atom-thick layer of carbon–to detect bacteria such as those that attack the stomach lining and that have been linked to stomach cancer. When the bacteria interact with the biosensor, chemical reactions are triggered which are detected by the graphene. To enable detection of the chemical reaction products, the researchers used microfluidics to contain the bacteria in extremely tiny droplets close to the sensor surface.

To get the bacteria to stick, the researchers covered the graphene with antibodies, a common way of anchoring bacteria to biosensor surfaces. However, although antibodies are very small (~10 nm), on the atomic scale and compared with the atom-thin layer of graphene, they are actually quite large and bulky. While the bacteria interact with the antibodies, the graphene cannot detect those bacteria directly as the antibodies on its surface block the signal; this signal blocking effect is referred to as Debye screening.

To overcome the Debye screening limitation, the researchers instead decided to monitor chemical reactions being performed by the bacteria in the presence of certain chemicals, which they added to the tiny water droplet. The chemicals produced in the reactions are far smaller than the antibodies and can slip between them easily and reach the graphene surface. By only analyzing the bacteria in tiny droplets generated through microfluidics, the bacteria and their reaction products can be kept close to the graphene surface and the concentration of the reaction products can even be monitored over time.

“Our biosensor enables highly sensitive and quantitative detection of bacteria that cause stomach ulcers and stomach cancer by limiting its reaction in a well-defined microvolume,” study co-author Kazuhiko Matsumoto says.

The graphene sensing surface is able to feedback electrical signals that vary depending on how much of the reaction product is present in the microdroplet and how quickly it is accumulating. These electrical signals can be used to calculate the number of bacteria in the droplet. The graphene is set-up in a field effect transistor (FET) structure, the role of which is to dramatically increase the electrical detection signals from the graphene sensing surface.

“Our biosensor is essentially a mini laboratory on a graphene FET. This sensor demonstrates how two-dimensional materials such as graphene are getting closer to being applied in practical medical and healthcare applications,” first author Takao Ono says.

The results of the study can be used to create a whole host of these “lab-on-a-graphene-FET” biosensors to detect various different bacteria. The detection of tiny concentrations of bacteria could be achieved in less than 30 minutes; hence, this work represents the possibility of faster diagnoses for potentially harmful bacteria in future.

###

The article, “Electrical Biosensing at Physiological Ionic Strength Using Graphene Field-Effect Transistor in Femtoliter Microdroplet” was published in Nano Letters at DOI: 10.1021/acs.nanolett.9b01335

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan’s leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan’s most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university’s ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: https://resou.osaka-u.ac.jp/en/top

Media Contact
Saori Obayashi
[email protected]

Original Source

https://pubs.acs.org/doi/abs/10.1021/acs.nanolett.9b01335

Related Journal Article

http://dx.doi.org/10.1021/acs.nanolett.9b01335

Tags: BiologyChemistry/Physics/Materials SciencesDiagnosticsMedicine/Health
Share12Tweet7Share2ShareShareShare1

Related Posts

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.